Trial Profile
Optimizing Patient Centered-Care: A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA Trial)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone (Primary) ; Methadone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Acronyms OPTIMA
- 15 Jun 2022 Primary endpoint has been met. (Opioid Use), as per Results published in the American Journal of Psychiatry
- 15 Jun 2022 Results published in the American Journal of Psychiatry
- 11 Jun 2021 Status changed from recruiting to completed.